persistent asthma
Item
persistent asthma for at least 1-year
boolean
C3266628 (UMLS CUI [1])
asthma therapy; corticosteroid
Item
must use a daily asthma controller medication for at least 4 weeks prior to randomization, including an inhaled corticosteroid (ics) with or without a long-acting beta agonist (laba) or other adjunctive asthma therapy or be using a leukotriene receptor antagonist (ltra), xanthine or short acting beta agonist (saba) as a monotherapy.
boolean
C0087111 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C3536709 (UMLS CUI [2])
medication asthma
Item
must be able to discontinue current asthma medication
boolean
C0013227 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
asthma exacerbation
Item
must have a history of at least one asthma exacerbation in previous 4 to 52 weeks
boolean
C0349790 (UMLS CUI [1])
Unstable status asthma
Item
unstable asthma
boolean
C0443343 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
corticosteroid; Adjuvant therapy
Item
taking high dose ics with or without other adjunctive therapy who have an asthma control questionnaire 6 (acq6) total score ≥ 1.5
boolean
C0001617 (UMLS CUI [1])
C0677850 (UMLS CUI [2])
xanthine
Item
taking ltra, xanthine or saba monotherapy with an acq-6 total score < 1.5 (controlled)
boolean
C3541955 (UMLS CUI [1])
comorbidity Lung diseases
Item
chronic obstructive pulmonary disease (copd), cystic fibrosis (cf), or other significant, non-asthmatic, lung disease
boolean
C0009488 (UMLS CUI [1,1])
C0024115 (UMLS CUI [1,2])
comorbidity
Item
clinically significant abnormality, illness or disorder of any body or organ system
boolean
C0009488 (UMLS CUI [1])
comorbidity Cardiovascular Diseases; medication contraindication beta agonist
Item
significant underlying cardiovascular condition which may contraindicate use of a beta-agonist.
boolean
C0009488 (UMLS CUI [1,1])
C0007222 (UMLS CUI [1,2])
C3699431 (UMLS CUI [2,1])
C0001644 (UMLS CUI [2,2])
smoking status
Item
history of smoking greater than 10-pack years
boolean
C1519386 (UMLS CUI [1])
asthma exacerbation
Item
had an asthma exacerbation within 4 weeks of the baseline visit
boolean
C0349790 (UMLS CUI [1])
asthma exacerbation hospitalization
Item
had more than 4 asthma exacerbations or 2 hospitalizations within 52 weeks of the randomization visit
boolean
C0349790 (UMLS CUI [1,1])
C0019993 (UMLS CUI [1,2])
hypersensitivity corticosteroids
Item
known or suspected hypersensitivity or intolerance to corticosteroids, beta-2 agonists, or any of the (inactive ingredients) excipients present in the medications used in this study
boolean
C0020517 (UMLS CUI [1,1])
C0001617 (UMLS CUI [1,2])
antibodies; systemic steroids
Item
require the use of chronic systemic steroids, omalizumab, or other monoclonal or polyclonal antibodies
boolean
C0003241 (UMLS CUI [1])
C2825233 (UMLS CUI [2])
beta-blockers
Item
requires the use of beta-blockers
boolean
C0304516 (UMLS CUI [1])
severe asthma; intubation; hypercapnia
Item
history of life-threatening asthma, including an asthma episode that required intubation and/or was associated with hypercapnia requiring noninvasive ventilatory support
boolean
C0581126 (UMLS CUI [1])
C0021925 (UMLS CUI [2])
C0020440 (UMLS CUI [3])
pregnancy; lactating
Item
lactating, pregnant, or plans to become pregnant during the course of the trial
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])